BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19239562)

  • 1. Leukocyte adsorption apheresis for the treatment of pyoderma gangrenosum.
    Watanabe Y; Yamada H
    J Dermatol; 2008 Dec; 35(12):792-4. PubMed ID: 19239562
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum.
    Kanekura T; Maruyama I; Kanzaki T
    J Am Acad Dermatol; 2002 Aug; 47(2):320-1. PubMed ID: 12140486
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocytapheresis treatment for pyoderma gangrenosum.
    Fujimoto E; Fujimoto N; Kuroda K; Tajima S
    Br J Dermatol; 2004 Nov; 151(5):1090-2. PubMed ID: 15541092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
    Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
    Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
    Kanekura T; Kawahara K; Maruyama I; Kanzaki T
    Ther Apher Dial; 2005 Aug; 9(4):292-6. PubMed ID: 16076369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease.
    Hanafusa T; Azukizawa H; Umegaki N; Tani M; Yamaguchi Y; Katayama I
    J Dermatol; 2011 May; 38(5):507-10. PubMed ID: 21352279
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
    Russo I; Miotto S; Colpo A; Marson P; Tison T; Ferrazzi A; Alaibac M
    Int Wound J; 2017 Feb; 14(1):282-284. PubMed ID: 27790848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum in the head and neck.
    Wittekindt C; Lüers JC; Klussmann JP; Hüttenbrink KB
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):83-5. PubMed ID: 17224531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyoderma gangrenosum: a rare pathology or an omitted diagnosis?].
    Lê Huu S; Spertini F; Roggero P; Egloff DV; Raffoul W
    Ann Chir Plast Esthet; 2009 Feb; 54(1):82-7. PubMed ID: 18938011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis.
    Kawakami T; Yamazaki M; Soma Y
    Am J Gastroenterol; 2009 Sep; 104(9):2363-4. PubMed ID: 19727102
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyoderma gangrenosum treatment: a steroid-free option.
    Conwell P; Mikulski L; Moran D; Tramontozzi M
    Ostomy Wound Manage; 2004 May; 50(5):26-8. PubMed ID: 15379405
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hyperbaric oxygen therapy as an adjuvant treatment for pyoderma gangrenosum].
    Herfarth AE; Martínez-Ramos D; Nomdedeu-Guinot J; Salvador-Sanchis JL
    Cir Esp; 2009 May; 85(5):319-21. PubMed ID: 19375074
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyoderma gangrenosum.
    Powell J; Wojnarowska F; Charnock M; Millard P
    Lancet; 1998 May; 351(9112):1366. PubMed ID: 9643839
    [No Abstract]   [Full Text] [Related]  

  • 14. A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.
    Okuma K; Mitsuishi K; Hasegawa T; Tsuchihashi H; Ogawa H; Ikeda S
    Ther Apher Dial; 2007 Oct; 11(5):387-90. PubMed ID: 17845399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum of the penis: an important lesson.
    Ng E; Lee M; Dunglison N
    ANZ J Surg; 2015 Jan; 85(1-2):91-2. PubMed ID: 24171720
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyoderma gangrenosum of the penis: a potentially dramatic skin disease.
    Georgala S; Georgala C; Nicolaidou E
    Urology; 2008 Nov; 72(5):1185.e9-10. PubMed ID: 18314174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Er: YAG Laser Ablation: An Adjuvant Treatment for Medically Resistant Pyoderma Gangrenosum.
    Çalişkan E
    Dermatol Surg; 2017 Nov; 43(11):1405-1407. PubMed ID: 28272082
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory pyoderma gangrenosum peristomal ulcer and sinus tract treated with micronized cadaveric dermis.
    Levy D; Banta MR; Kirsner RS
    J Am Acad Dermatol; 2005 Jun; 52(6):1104. PubMed ID: 15928642
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis Syndrome Treated with Granulocyte and Monocyte Adsorption Apheresis.
    Mizutani Y; Okano T; Takahashi T; Ohnishi H; Ohara O; Sano A; Seishima M
    Acta Derm Venereol; 2017 Feb; 97(2):275-276. PubMed ID: 27384061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.